116 related articles for article (PubMed ID: 6945881)
1. Phenotypic evaluation of chronic myeloid leukemia.
Moore MA; Mertelsmann R; Pelus LM
Blood Cells; 1981; 7(2):217-36. PubMed ID: 6945881
[TBL] [Abstract][Full Text] [Related]
2. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
4. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
5. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
[TBL] [Abstract][Full Text] [Related]
6. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
7. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
8. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
Freedman MH; Hitzler JK; Bunin N; Grunberger T; Squire J
Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
[TBL] [Abstract][Full Text] [Related]
9. Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin.
Nilsson B; Olofsson T; Olsson I
Exp Hematol; 1984 Feb; 12(2):91-9. PubMed ID: 6583069
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
12. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic leukemia.
Katayama T; Miura Y; Suda T; Kusumoto K; Ozawa K; Motoyashi K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(6):345-54. PubMed ID: 6183760
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
16. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia].
Nara N
Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492
[TBL] [Abstract][Full Text] [Related]
17. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
18. Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia.
Schwab R; Peschel C; Desprès D; Derigs G; Fischer T; Huber C; Aulitzky WE
Cytokines Mol Ther; 1995 Dec; 1(4):281-8. PubMed ID: 9384681
[TBL] [Abstract][Full Text] [Related]
19. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders.
Taetle R; Guittard JP; Mendelsohn JM
Exp Hematol; 1980 Nov; 8(10):1190-1201. PubMed ID: 6971757
[TBL] [Abstract][Full Text] [Related]
20. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1.
Aglietta M; Piacibello W; Gavosto F
Cancer Res; 1980 Jul; 40(7):2507-11. PubMed ID: 6930323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
